xenoAMPs-poly(I:C) complexes activate inflammation and coagulation processes. Bronchial epithelial cells (BEAS-2B, n = 4, A), primary Human Aortic Endothelial Cells (HAoEC, n = 4, B) and human umbilical vein cells (EA.hy926, n = 6, C and D) are treated with xenoAMP-poly(I:C), poly(I:C) or the associated controls. The released cytokines (IL-6 and IL-8) in the supernatant are quantified to evaluate the immune activation. The tissue factor (TF) activity is measured by a two-stage Factor Xa activity assay. (n=6, E) Representative results are shown from at least three independent experiments. Data is presented as mean ± SD. The statistical analysis is performed using one-way ANOVA. (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).